Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT

Retrospective Studies

Myelodysplastic (MDS) or MDS/MPN

Chronic Malignancies Working Party (CMWP)

Type of treatment

Principal investigator

Prevention and management of conditioning related skin toxicity in paediatric HSCT patients

Closed Survey/Study

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Mihaela Hartmann, Hilda Mekelenkamp

Prévention et gestion de la toxicité cutanée liée à la préparation chez les patients pédiatriques en greffe de cellules souches hématopoïétiques (HSCT)

Toutes les maladies

Nursing Research Committee

Nursing Paediatric Committee

Paediatric Diseases Working Party (PDWP)

Type of treatment

Principal investigator

Mihaela Hartmann, Hilda Mekelenkamp

Machine Learning grading system for acute graft-versus host disease

Retrospective Studies

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Steroid refractory acute graft-versus-host disease - survey

Transplant Complications Working Party (TCWP)

Type of treatment

Principal investigator

Renal failure in aplastic anemia

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

Beatrice Drexler

Outcomes of treatment with anti thymocyte globulin (ATG) for acquired pure red cell aplasia

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

RACE-2: long-term follow-up of patients participating in RACE: the prospective Randomized multicenter study comparing horse Antithymocyte globuline (hATG) + Cyclosporine A (CsA) with or without Eltrombopag as front-line therapy for Severe Aplastic Anemia patients

Non-interventional Prospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Immunosuppressive Treatment (IST)

Principal investigator

Régis Peffault de Latour, Antonio M. Risitano

Clonal evolution in acquired aplastic anemia

Retrospective Studies

Bone marrow failure

Severe Aplastic Anaemia Working Party (SAAWP)

Type of treatment

Principal investigator

Pedro de Lima Prata

Real life analysis BV use as consolidation therapy in HL with high risk post ASCT

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Mariana Bastos Oreiro

Outcomes of Allogeneic HCT in patients with Hodgkin Lymphoma in the era of Checkpoint Inhibitors: A joint CIBMTR and EBMT analysis.

Retrospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Miguel-Angel Perales

Allogeneic Stem Cell TransplantationIn NK/ T-cell lymphoma

Retrospective Studies

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Norbert Schmitz